Lawrence Joseph
Bayesian statistics
Professor
E-mail: lawrence.joseph@mcgill.ca
Telephone: +1 (514) 934-1934 ext: 44713
FAX: (514) 934-8293
Complete CV
Division of Clinical Epidemiology
McGill University Health Centre
Royal Victoria Hospital
687 Pine Avenue West
V Building, Room V2.10
Montreal, Quebec
Canada, H3A 1A1
Allergy and immunology Asthma Cardiology Gastroenterology Osteoporosis Quality of Life Rheumatology Other
Complete CV
Research interests
Courses taught
EPIB-607 Principles of Inferential Statistics in Medicine
EPIB-613 Introduction to Statistical Software
EPIB-621 Data Analysis in the Health Sciences
EPIB-651 Bayesian Analysis in Medicine
EPIB-675 Bayesian Analysis in the Health Sciences
Publications
Methodological publications
Bayesian Sample Size
Change-point methods and applications
Diagnostic testing
Meta analysis
Other topics
Medical publications
Allergy and immunology
Asthma
Cardiology
Gastroenterology
Osteoporosis
Quality of Life
Rheumatology
Other
Book
Bayesian software
Bayesian Sample Size
Change-point methods and applications
Diagnostic testing
Diagnostic testing in Genetics
Links
Manjoo P, Joseph L, Dasgupta K.
Abdominal adiposity and daily step counts as determinants of glycemic control in a cohort of patients with type 2 diabetes mellitus
Nutrition and Diabetes 2012 (epub ahead of print)
Jarvandi S, Joseph L, Gougeon R, Dasgupta K.
Vitamin supplementation and blood pressure in type 2 diabetes
Diabetic Medicine (Accepted)
Filion K, Joseph L, Boivin J, Suissa S, Brophy J.
Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus
Pharmacoepidemiology and Drug Safety 2011;20(8):785-796
Dasgupta K, Joseph L, Pilote L, Strachan I, Sigal R, Cathy C.
Daily steps are low year-round and dip lower in fall/winter: findings from a longitudinal diabetes cohort
Cardiovascular Diabetology 2010;9(81):1-9
Manjoo P, Joseph L, Pilote L, Dasgupta K.
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes
Obesity 2010;5(11):1-6
Mottillo S, Filion K, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin E, Eisenberg M.
The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis
Journal of the American College of Cardiology 2010;56:1113-1132
Mongeon F, Bélisle P, Joseph L, Ismail S, Eisenberg M, Rinfret S.
Adjunctive thrombectomy for acute myocardial infarction: A Bayesian meta-analysis
Circulation: Cardiovascular Interventions 2010;3 (1):6-16
Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy J.
Therapeutic management in patients with renal failure who experience an acute coronary syndrome
Clinical Journal of American Society of Nephrology 2010;5(1):87-94
Cardinal H, Brophy J, Bogaty P, Joseph L, Hébert M, Boyer L, Madore F.
Usefulness of sFas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes
American Journal of Cardiology 2010;105 (6):797-803
Eisenberg M, Blum L, Filion K, Rinfret S, Pilote L, Paradis G, Joseph L, Gervais A, O'Loughlin J.
The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials
Canadian Journal of Cardiology 2010;26(2):73-79
Abourbih S, Filion K, Joseph L, Schiffrin E, Rinfret S, Poirier P, Pilote L, Genest J, Eisenberg J.
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review
American Journal of Medicine 2009;122(10):962-969
Grover S, Kaouache M, Joseph L, Barter P, Davignon J.
Evaluating the incremental benefits of raising high density lipoprotein cholesterol during lipid therapy after adjustment for the reductions in other blood lipid levels
Archives of Internal Medicine 2009;169(19):1775-1780
Filion K, Joseph L, Boivin J, Suissa S, Brophy J.
Trends in the prescription of anti-diabetic medications in the United Kingdom: A population-based analysis
Pharmacoepidemiology and Drug Safety 2009;18(10):973-976
Huynh T, Perron S, O'Loughlin J, Joseph L, Labrecque M, Dery V, Tu J, Théroux P.
Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment elevation myocardial infarction - Bayesian hierarchical meta-analyses of randomized controlled trials and observational studies
Circulation 2009;119(24):3101-3109
Grover S, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G.
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study
Journal of General Internal Medicine 2009;24(1):33-39
Pilote L, Beck C, Eisenberg M, Humphries K, Joseph L Penrod J, Tu J.
Comparing invasive and non-invasive management strategies for acute myocardial infarction using administrative databases
The American Heart Journal 2008;155(1):42-48
Dasgupta K, Chan C, Da Costa D, Pilote L, De Civita M, Ross N, Strachan I, Sigal R Joseph L.
Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences -- Study design and methods
Cardiovascular Diabetology 2007;6(1):1-27
Pilote L, Tu J, Humphries K, Behouli H, Bélisle P, Austin P, Joseph L.
Socioeconomic status and access to health care after acute myocardial infarction in Canada
Medical Care 2007;45(7):638-646
Grover S, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G, Fazal-Karim K, Pakos T.
Can assessing cardiovascular risk increase the effectiveness of dyslipidemia therapy? The CHECK-UP Study: A randomized controlled trial
Archives of Internal Medicine 2007;167(21):2296-2303
Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, Kouz M, Nguyen M, Harvey R, Cantin B, Paradis G, Pilote L, Eisenberg M.
Time delay to reperfusion therapy in acute ST-Elevation myocardial infarction: Results from the AMI-QUEBEC Study
Canadian Medical Association Journal 2006;175(12):1527-1532
Grover S, Hemmelgarn B, Joseph L, Milot A, Tremblay G.
The role of global risk assessment in hypertension therapy
Canadian Journal of Cardiology 2006;22(7):606-613
Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Joseph L, Dagenais G.
Fluctuating inflammatory markers in patients with stable ischemic heart disease
Archives of Internal Medicine 2005;165:221-226
Lalonde L, O'Connor A, Joseph L, Grover S.
Health related quality of life in cardiac patients with hypertension and dyslipidemia
Quality of Life Research 2004;13(4):793-804
Pilote L, Joseph L, Bélisle P, Penrod J.
Universal health insurance coverage does not eliminate inequities in access to cardiac procedures after acute myocardial infarction
American Heart Journal 2003;146(6):1030-1037
Pilote L, Green L, Joseph L, Richard H, Eisenberg M.
Antibiotics against chlamydia pneumoniae and prognosis after acute myocardial infarction
American Heart Journal 2002;143(2):294-300
Pilote L, Lauzon C, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Levesque C, Charbonneau F, Pouliot J, Joseph L, Eisenberg MJ.
Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography
Archives of Internal Medicine 2002;162(5):553-559
Doucet M, Eisenberg M, Joseph L, Pilote L.
Effects of hospital volume on long term outcome after percutaneous transluminal coronary angioplasty after myocardial infarction
American Heart Journal 2002;144(1):144-150
Beck C, Joseph L, Bélisle P, Pilote L.
Predictors of quality of life 6 months and 1 year after acute myocardial infarction
American Heart Journal 2001;142(2):271-279
Lalonde L, Clarke A, Joseph L, Mackenzie T, Grover S.
Health related quality of life with coronary heart disease prevention and treatment
Journal of Clinical Epidemiology 2001;54(10):1011-8
Lalonde L, Clarke A, Joseph L, Mackenzie T, Grover S, and the Canadian Collaborative Cardiac Assessment Group.
Comparing the psychometric properties of preference-based and nonpreference-based health related quality of life in coronary heart disease. Quality of Life Research
Quality of Life Research 1999;8(5):399-409
Lowensteyn I, Joseph L, Levinton C, Abrahamowicz M, Steinert Y, Grover S.
Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS)
Preventive Medicine 1998;27(5):730-737
Rosenberg E, Lamping D, Joseph L, Pless I, Franco E.
Cholesterol screening of children at high risk: Behavioral and psychological effects
Canadian Medical Association Journal 1997;156(4):489-496
Lowensteyn I, Joseph L, Grover S.
Who needs an exercise test? Evaluating the new American College of Sports Medicine risk stratification guidelines
Journal of Cardiopulmonary Rehabilitation 1997;17:253-260
Esrey KL, Joseph L, Grover SA.
The relationship between dietary intake and coronary heart disease mortality: the lipid research clinics prevalence follow-up study
Journal of Clinical Epidemiology 1996;49:211,216
Grover SA, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M.
Do doctors accurately assess the coronary risk of their patients? Preliminary results of the coronary health assessment study
British Medical Journal 1995;310:975-978
Grover SA, Gray-Donald K, Joseph L, Abrahamowicz M, Coupal L.
Life expectancy following dietary modification or smoking cessation: estimating the benefits of a prudent lifestyle
Archives of Internal Medicine 1994;154:1697-1704